Barinthus Biotherapeutics plc annual current ratio
2020
2021
2022
2023
2024
2025
Barinthus Biotherapeutics plc Current Ratio Growth & History (BRNS)
Barinthus Biotherapeutics plc's current ratio was 7.77 for fiscal 2025.
View full Barinthus Biotherapeutics plc company overviewBarinthus Biotherapeutics plc annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 7.77 | −0.27 | −3.31% |
| 2024 | 2024-12-31 | 8.03 | −4.42 | −35.52% |
| 2023 | 2023-12-31 | 12.45 | −4.95 | −28.43% |
| 2022 | 2022-12-31 | 17.40 | −2.92 | −14.37% |
| 2021 | 2021-12-31 | 20.32 | 14.05 | +224.19% |
| 2020 | 2020-12-31 | 6.27 | — | — |
Barinthus Biotherapeutics plc quarterly current ratio
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 5.54 | −2.35 | −29.81% |
| Q1 2026 | 2026-03-31 | 6.05 | −3.12 | −34.01% |
| Q4 2025 | 2025-12-31 | 7.77 | −0.27 | −3.31% |
| Q3 2025 | 2025-09-30 | 8.04 | −0.90 | −10.04% |
| Q2 2025 | 2025-06-30 | 7.89 | −0.57 | −6.72% |
| Q1 2025 | 2025-03-31 | 9.18 | −1.98 | −17.72% |
| Q4 2024 | 2024-12-31 | 8.03 | −4.42 | −35.52% |
| Q3 2024 | 2024-09-30 | 8.93 | −0.28 | −3.02% |
| Q2 2024 | 2024-06-30 | 8.46 | −6.80 | −44.55% |
| Q1 2024 | 2024-03-31 | 11.15 | −5.59 | −33.38% |
| Q4 2023 | 2023-12-31 | 12.45 | −4.95 | −28.43% |
| Q3 2023 | 2023-09-30 | 9.21 | −6.37 | −40.88% |
| Q2 2023 | 2023-06-30 | 15.26 | −3.34 | −17.97% |
| Q1 2023 | 2023-03-31 | 16.74 | 2.74 | +19.55% |
| Q4 2022 | 2022-12-31 | 17.40 | −2.92 | −14.37% |
| Q3 2022 | 2022-09-30 | 15.58 | −23.02 | −59.64% |
| Q2 2022 | 2022-06-30 | 18.60 | −11.45 | −38.10% |
| Q1 2022 | 2022-03-31 | 14.00 | −4.88 | −25.86% |
| Q4 2021 | 2021-12-31 | 20.32 | 14.05 | +224.19% |
| Q3 2021 | 2021-09-30 | 38.60 | — | — |
| Q2 2021 | 2021-06-30 | 30.05 | — | — |
| Q1 2021 | 2021-03-31 | 18.89 | — | — |
| Q4 2020 | 2020-12-31 | 6.27 | — | — |
Barinthus Biotherapeutics plc current ratio trends
Over the last five fiscal years, Barinthus Biotherapeutics plc's current ratio increased from 6.27 to 7.77, a change of 1.50. The latest reported quarter, Q2 2026, shows 5.54.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Barinthus Biotherapeutics plc source filings ↗